Oxybro Plus Tablet SR is a combination medication containing Acebrophylline 200mg and Montelukast 10mg, formulated to provide sustained relief in respiratory conditions characterized by bronchoconstriction and inflammation. Acebrophylline acts as a bronchodilator with mucolytic properties, facilitating the relaxation of airway muscles and enhancing mucus clearance, thereby improving airflow in obstructive pulmonary diseases such as chronic bronchitis and asthma. Montelukast, a leukotriene receptor antagonist, targets inflammatory pathways by inhibiting leukotriene-mediated bronchoconstriction and edema, contributing to long-term control of asthma symptoms and prevention of exercise-induced bronchospasm. The sustained-release formulation ensures prolonged therapeutic effect, optimizing patient compliance by reducing dosing frequency. Oxybro Plus is indicated for the management of chronic obstructive pulmonary disease (COPD), asthma, and other respiratory disorders where both bronchospasm and inflammation are present. It should be used under medical supervision, with caution in patients with hepatic impairment or hypersensitivity to any component. Common adverse effects may include headache, gastrointestinal discomfort, and mild allergic reactions. Regular monitoring and adherence to prescribed dosage are essential to maximize benefits and minimize risks. Oxybro Plus Tablet SR offers a comprehensive approach to respiratory care by combining bronchodilation and anti-inflammatory action in a single, convenient dosage form.